FDA Inspection 1214674 - Aspire Pharmaceuticals, Inc. - July 14, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aspire Pharmaceuticals, Inc.

Record Details

This FDA Inspection record concerns Aspire Pharmaceuticals, Inc., with an inspection on July 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Aspire Pharmaceuticals, Inc.
Inspection Date: July 14, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 2e3308b0-d7a8-4945-bce1-1cca2332f47f

FDA Inspection

Aspire Pharmaceuticals, Inc.July 14, 2023